Marijuana extract sharply cuts seizures in severe form of epilepsy - Cannabis News

An oil derived from the marijuana plant sharply reduces violent seizures in young people suffering from a rare, severe form of epilepsy, according to a study published Wednesday that gives more hope to parents who have been clamoring for access to the medication.

Continue reading

Marijuana extract helps children with rare epilepsy in Phase 3 clinical trial – Cannabis News

Marijuana extract reduces seizures in patients with Lennox-Gastaut Syndrome in clinical trial.

Continue reading

GW Pharma's cannabis drug gets orphan drug status – Marijuana News

The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.

Continue reading

Marijuana-Based Drug Found to Reduce Epileptic Seizures – Marijuana News

An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced Monday, a finding that could lend credence to the medical marijuana movement.

Continue reading

Cannabis specialist GW Pharma ramps up capacity ahead of key drug approval – Marijuana News

A laboratory analysis of GW Pharmaceuticals' cannabis samples of Sativex. Image: PA via   Telegraph.co.uk

GW Pharmaceuticals, which makes drugs derived from the cannabis plant, is scaling up its manufacturing capacity ahead of an expected approval of a new treatment for children with life-threatening epilepsy.

Continue reading

WeedLife.com